{"wiki_id": "http://www.wikidata.org/entity/Q27058352", "itemLabel": "Emma Walmsley", "itemDescription": "British businesswoman, CEO of GlaxoSmithKline", "wikipedia_url": "https://en.wikipedia.org/wiki/Emma_Walmsley", "wikipedia_page": {"main": "Dame Emma Natasha Walmsley  (born June 1969) is the chief executive officer (CEO) of GlaxoSmithKline.  She succeeded Sir Andrew Witty, who retired in March 2017. Before GSK, she worked for L'Or\u00e9al for 17 years, and was a non-executive director of Diageo until September 2016. She grew up Barrow-in-Furness, Cumbria.\n\n", "link_mentions": [{"page": "Microsoft", "response": ["The company is run by a board of directors made up of mostly company outsiders, as is customary for publicly traded companies. Members of the board of directors as of July 2020 are  Satya Nadella, Reid Hoffman, Hugh Johnston, Teri List-Stoll, Sandi Peterson, Penny Pritzker, Charles Scharf, Arne Sorenson, John W. Stanton, John W. Thompson, Emma Walmsley and Padmasree Warrior. Board members are elected every year at the annual shareholders' meeting using a majority vote system. There are four committees within the board that oversee more specific matters. These committees include the Audit Committee, which handles accounting issues with the company including auditing and reporting; the Compensation Committee, which approves compensation for the CEO and other employees of the company; the Governance and Nominating Committee, which handles various corporate matters including the nomination of the board; and the Regulatory and Public Policy Committee, which includes legal/antitrust matters, along with privacy, trade, digital safety, artificial intelligence, and environmental sustainability."]}, {"page": "GlaxoSmithKline", "response": ["On 31 March 2017, Emma Walmsley became CEO. She is the first female CEO of the company."]}, {"page": "List of chief executive officers", "response": ["| Emma Walmsley"]}]}}